Sania Therapeutics

Online Valuation Platform

Sania Therapeutics is building precision gene therapies, combining targeted delivery of a therapeutic with a titratable activator to redefine nervous system therapies and maximize safety and efficacy.

Sania’s proprietary platform takes a “human-first” approach, recreating human neural circuits in the lab to develop cell-type specific gene delivery vectors. Sania’s system for neuromodulation normalizes electrical activity in these neural circuits, allowing them to treat a broad range of prevalent disorders.

SECTOR

Health Sciences

INVESTED

2023

STATUS

Active

HQ

London, UK

FOUNDERS

Andy Murray, PhD
Robert Brownstone, MD/PhD
Raj Dattani, BMBCh

Subscribe to hear about Arc Ventures' updates and events.

Make the Connection.

ARC VENTURES

655 Third Ave
FL 28
New York, NY 10017
United States

655 Third Ave FL 28
New York, NY 10017
United States

+1 (212) 702-5989
[email protected]

© 2024 ARC VENTURES | POWERED BY DIGITAL MULES